ETRASIMOD 2MG ONCE DAILY AS TREATMENT FOR BIOLOGIC/JANUS KINASE INHIBITOR-NAÏVE AND -EXPERIENCED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: SUBGROUP ANALYSIS FROM THE PHASE 3 ELEVATE UC 52 AND ELEVATE UC 12 TRIALS

Brian G. Feagan  1     Laurent Peyrin-Biroulet  2     William Sandborn  3     Geert R. D'Haens  4     Julian Panés  5     Andres Yarur  6     Douglas C. Wolf  7     Timothy Ritter  8     Stefan Schreiber  9     Sheldon Sloan  10     Fabio Cataldi  10     Kevin Shan  10     Christopher J. Rabbat  10     Michael Chiorean  11     Filip Baert  12     Bruce E. Sands  13     Marla C. Dubinsky  14     Severine Vermeire  15     Martina Goetsch  16     Silvio Danese  17    
1 Alimentive Inc / University of Western Ontario, London, Canada
2 Université de Lorraine, CHRU-Nancy, Nancy, France
3 University of California San Diego School of Medicine, La Jolla, United States
4 University of Amsterdam, Amsterdam, Netherlands
5 Hospital Clínic de Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
6 Cedars-Sinai Medical Center, Los Angeles, United States
7 Atlanta Gastroenterology Associates, Atlanta, United States
8 GI Alliance Research, Southlake, United States
9 University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany
10 Arena Pharmaceuticals, a wholly-owned subsidiary of Pfizer Inc, New York, San Diego, United States
11 IBD Center, Swedish Medical Center, Seattle, United States
12 Az Delta, Roeselare, Belgium
13 Icahn School of Medicine at Mount Sinai, New York, United States
14 Feinstein IBD Center, Mount Sinai, New York, United States
15 University Hospitals Leuven, Leuven, Belgium
16 Arena Pharmaceuticals Development GmbH, a wholly-owned subsidiary of Pfizer Inc, New York, Zug, Switzerland
17 IRCCS Ospedale San Raffaele and University Vita-Salute San Raffaele, Milan, Italy

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing